June 2023 edition of MEDOSCOPY with Mercy Dr. Sabrina Barata (left) and Dr. Sara Encisco

BALTIMORE (PRWEB)
May 31, 2023

Sabrina Barata, M.D., a primary care physician fluent in Spanish and Portuguese, and Sara Encisco, M.D., who specializes in Internal Medicine and Pediatrics, are the featured guests on Mercy Medical Center’s monthly talk show, “Medoscopy,” airing Tuesday and Wednesday, June 20th and 21st, at 5:30 p.m. EST on Facebook Watch (http://www.facebook.com/MercyMedicalCenter).

Drs. Barata and Encisco see patients at Mercy Personal Physicians in Lutherville.

A 30-minute pre-taped program exploring the background and lives of Mercy clinicians, patients and others, Medoscopy was launched in spring 2021 and airs in two 15-minute segments. To view past episodes, visit the Medoscopy playlist on the Mercy Medical Center YOUTUBE channel.

In this latest installment, Dr. Barata, a first-generation Brazilian-American, discusses her interest in working with the Latino population, focusing on preventive health and mental health disparities. Dr. Encisco examines her interest in the rise of new-onset diabetes in children during the COVID-19 pandemic.

Both Dr. Barata and Dr. Encisco share items of interest to their personal lives and careers during the program’s regular “show and tell” feature, and Dr. Encisco stays after the credits for Medoscopy’s “Wait, Doctor, I Forgot to Ask!” segment.

Medoscopy is filmed on the campus of Mercy Medical Center in downtown Baltimore with video, sound, and lighting by Zinnia Film.

Founded in 1874 by the Sisters of Mercy, Mercy Medical Center is located in downtown Baltimore City, about six blocks from Baltimore’s famed Inner Harbor. A university-affiliated teaching facility, Mercy is a Catholic hospital with a national reputation for women’s health care, orthopedics, and other specialties. Mercy is home to the renowned Weinberg Center for Women’s Health & Medicine, and the $400+ million Mary Catherine Bunting Center. For more information, visit http://www.mdmercy.com, and MDMercyMedia on Facebook and Twitter, or call 1-800-M.D.-Mercy.

Share article on social media or email:

“Grambling State is only the first stop on a national tour to bring needed care to an underserved community,” says Nexus Spokesperson and NFL Hall of Famer, Mel Blount.

GRAMBLING, La. (PRWEB)
May 31, 2023

Nexus Dental Systems (Nexus) launched a national initiative to screen, test and treat Obstructive Sleep Apnea in the HBCU community. The program kicked off on May 22nd, 2023 with the Grambling State University Tigers football team, Coaching Staff and Administrators. Screening for the broader Grambling State University community begins in the fall of 2023.

This program consists of public screening events on HBCU campuses in partnership with local care providers. Nexus provides support through public outreach, onsite training for local volunteers and national insurance contracts.

“This program is part of our core mission as a company; expanding access to care for Obstructive Sleep Apnea care through education, training, technology, medical billing and patient outreach,” says Brett Brocki, Founder and CEO of Nexus Dental Systems.

Grambling State University and Nexus have partnered with Dr. Tony Soileau, DDS, Dr. Matthew Abraham, MD, VirtuOx Sleep Testing, Somnomed North America (Oral Appliance Therapy), ICAN Apparel and a dedicated team of volunteers to bring a fully turn-key event for OSA screening, testing and treatment to the Grambling State University community.

The idea for this program came from G-Men Nation, Inc. who introduced Nexus to the Grambling State Team. ​Herman J. Arvie, Executive Director of G-Men Nation, Inc., himself a Grambling alumni and former NFL Offensive Lineman explains, “As someone who suffered with undiagnosed OSA for years – we need more early screening. Good sleep is critical to athletic performance, academic performance, mental focus, recovery and healing – it’s absolutely critical.”

“Grambling State is only the first stop on a national tour to bring needed care to an underserved community,” says Nexus Spokesperson and NFL Hall of Famer, Mel Blount, “As a historical fact, HBCUs are usually the last to receive attention from programs like this. We congratulate Grambling State University and Nexus Dental Systems working together to bring awareness to this important issue.”

ICAN Apparel founder Kelsey Battle adds, “Our mission is to empower athletes, and student athletes across the world to take control of their total health: physical, mental and social. This program is the first and only one like it, bringing healthcare directly to those most affected by this condition.”

Key OSA Facts:

• Many studies show that African Americans have increased risk for OSA
• A 2018 study found 24% of African American study participants had moderate to severe OSA, yet only 5% had been diagnosed¹
• A 20-year University of Buffalo study from 2022 found that more African American men die from OSA at a higher rate than any other group, and the rate has continued to grow despite downward trends in other populations²
• Among adults, adherence to continuous positive airway pressure (CPAP) is substantially lower in African Americans³
• African American men have more severe OSA when first diagnosed compared to other populations⁴

About Nexus Dental Systems:

Nexus Dental Systems is the only company in the market with a true end-to-end solution. Our conglomerate has the B2B expertise that fulfills the needs of a dental practice to: Identify, Screen, Treat and Monitor Sleep Treatment Compliance for Oral Appliance Therapy. Our mission is to raise public awareness of sleep apnea, train dentists to implement dental sleep medicine, create sleep apnea programs for the industry, and connect patients with providers by creating sustainable and resilient systems for providers and the public. For More Information Visit: https://nexusdentalsystems.com

About G-Men Nation, Inc.:

G-Men Nation, Inc. is an organization on a mission to support the successful growth and lively sustainment of the HBCU football program experience. To that end, the viable foci are to continue to maintain the elite status of being the premier intercollegiate organization in the nation, while providing the guidance and structure that permeate the G-Men band of brothers. As well, the awarding of academic and athletic scholarship will be offered to HBCU students who uphold the high standards of their university, and who devote time and effort to the uplifting of the football program.

About ICAN Clothing:

Since 1999, ICAN defined its brand as a positive life which serves as the DNA for positive fashion wear. ICAN is designed to meet a universal thought and deliver universal messages with style. ICAN customers become the brand when they believe ICAN. https://icanclothes.com/

About Louisiana Sleep Solutions:

Louisiana Sleep Solutions is a Lafayette, LA-based dental practice dedicated to the treatment of Obstructive Sleep Apnea. Dr. Tony Soileau began his work in Dental Sleep Medicine after diagnosed with Mild Obstructive Sleep Apnea in 2008. He was prescribed a CPAP with lower pressure settings but was unable to tolerate treatment. He discovered Oral Appliance Therapy at a dental conference, shortly after he received his first appliance and was hooked. https://louisianasleepsolutions.com/

About Skylink Medical:

Skylink Medical is a Lafayette, LA-based medical practice specializing in the treatment of Sleep Apnea. Dr. Matthew Abraham obtained his medical degree from Louisiana State University of Medicine in 1998. He is the sleep medicine director at a local hospital and operates a personalized telemedicine program for sleep medicine. Dr. Abraham is a sleep specialist practicing in sleep medicine for 20 years. https://skylinkmedical.com

About Somnomed, North America:

Founded in 2004, SomnoMed® is an Australian Stock Exchange listed medical device company operating in 28 countries. With headquarters in Sydney, Australia and offices in Europe and the United States, SomnoMed® focuses on developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). Patients around the world with mild and moderate OSA have been successfully treated with our oral appliances. https://somnomed.com/en/

About VirtuOx:

VirtuOx is a healthcare information technology company that provides diagnostic tools and services that enable a variety of healthcare organizations and professionals to diagnose and treat diseases through vertically integrated platforms, products and services.

Citations

(1) Dayna A Johnson and others, Prevalence and correlates of obstructive sleep apnea among African Americans: the Jackson Heart Sleep Study, Sleep, Volume 41, Issue 10, October 2018, zsy154, https://doi.org/10.1093/sleep/zsy154

(2) Yu-Che Lee, Ko-Yun Chang, M. Jeffery Mador, Racial disparity in sleep apnea-related mortality in the United States, Sleep Medicine,Volume 90, 2022, Pages 204-213, ISSN 1389-9457, https://doi.org/10.1016/j.sleep.2021.11.014.

(3) Dudley KA, Patel SR. Disparities and genetic risk factors in obstructive sleep apnea. Sleep Med. 2016 Feb;18:96-102. doi: 10.1016/j.sleep.2015.01.015. Epub 2015 Feb 27. PMID: 26428843; PMCID: PMC4602395.

(4) Thornton JD, Dudley KA, Saeed GJ, et al. Differences in symptoms and severity of obstructive sleep apnea between blacks and whites. Ann Am Thorac Soc. Published online July 9, 2021. doi:10.1513/AnnalsATS.202012-1483OC

###

Containing real fruit juices, 8th Wonder is infused with premium botanical ingredients like cardamom, ginger, ashwagandha, chai, and apple juice.

It was an absolute honor for 8th Wonder to be featured on such an esteemed and beloved program which is part and parcel of so many Americans’ daily routine. -Reed Rush, CEO and Co-Founder of 8th Wonder Tea

LOS ANGELES (PRWEB)
May 31, 2023

Today, 8th Wonder Tea is excited to announce that their line of organic sparkling superfood teas was featured on the TODAY Show with Hoda & Jenna on Friday, May 26th, ahead of the Memorial Day holiday weekend. One of the most popular, national daytime shows in the U.S., 8th Wonder was included in their summer entertaining segment as a must have item for B-B-Qs and outdoor get-togethers with friends and family this summer.

“It was an absolute honor for 8th Wonder to be featured on such an esteemed and beloved program which is part and parcel of so many Americans’ daily routine. We only hope that the glowing reception and warm reviews will encourage viewers to also include our organic functional beverages into that same cherished routine,” said Reed Rush, CEO and Co-Founder of 8th Wonder Tea. “Most of all, we want to thank everyone at NBC and particularly Hoda, Jenna, and Meredith Sinclair for believing in all the good stuff we are creating at 8th Wonder Tea. Here’s to wishing everyone the best in backyard fun this summer!”

In addition to their national television show debut in May, over the last six months 8th Wonder has also been featured with prominent national consumer, lifestyle, business, and industry trade publications including Men’s Health and OK! Magazine who included 8th Wonder in various holiday gift guides and roundups. Along with these, 8th Wonder has received business features with those such as World Tea News, BevNet and the California Business Journal.

Containing real fruit juices, 8th Wonder is infused with premium botanical ingredients like cardamom, ginger, ashwagandha, chai, and apple juice. 8th Wonder organic sparkling teas contain no added sugar, sugar alcohols, GMOs, or artificial ingredients. Additionally, 8th Wonder is certified organic, Whole30 approved, non-GMO project verified, paleo, vegan and Kosher certified. Offering gut health and immunity in addition to their delicious taste, 8th Wonder is packed with antioxidants, vitamins, minerals, anti-inflammatory properties, and other benefits that may help reduce inflammation throughout the body and the risk of chronic diseases.

According to the Global Organic Tea Markets latest research report in November 2022, the growing consumer preference for safe, chemical-free, and healthy consumables, is one of the most important factors driving market expansion along with a shift in lifestyle and growing demand from the personal care industry.

Launching on Amazon in November 2022, 8th Wonder has been available at select specialty grocers including Whole Foods in the Rocky Mountain region, Mother’s Market and Kitchen and Lassen’s Natural Foods and Vitamins in Southern California, and Pop Up Grocer in New York City in addition to their direct-to-consumer e-commerce site.

For more information on 8th Wonder Tea, visit: https://8thwondertea.com/.

###

About 8th Wonder Tea

8th Wonder Tea makes earth-conscious, organic sparkling superfood teas that deliver the enhanced benefits of premium botanical ingredients to fuel the body and mind. Capitalizing on the popularity of sparkling beverages, 8th Wonder offers the healthy attributes of premium teas by using the finest ingredients. Containing real fruit juices, 8th Wonder is certified organic, Whole30 approved, non-GMO project verified, paleo, vegan and Kosher certified. 8th Wonder contains no added sugar, sugar alcohols, GMOs, or artificial ingredients. 8th Wonder comes in five flavors and is available on Amazon. For more information on 8th Wonder, visit: https://8thwondertea.com/.

Share article on social media or email:

For the first time, people who care about breathing healthy air can easily measure indoor air quality without needing technical expertise or a large budget.

SAN DIEGO (PRWEB)
May 31, 2023

Following a strong Kickstarter campaign that exceeded its funding goal by 200%, IAQ is thrilled to announce its launch on Indiegogo, offering the revolutionary IAQ device at up to 50% off retail price.

IAQ is the most comprehensive home indoor air quality monitor available, capable of detecting more than 20 air pollutants. Its user-friendly design, easy setup, and extensive measuring capacity set it apart from other products on the market. The device is now available in packages of one, two, or five units, with a special Founder’s Edition that includes a custom case.

IAQ was founded out of a deep concern for air quality, and a recognition of the urgent need for accessible, accurate indoor air quality monitoring. A recent study by the American Lung Association revealed that a third of Americans are exposed to potentially harmful air pollution daily, highlighting the importance of IAQ’s mission.

The company’s founders discovered that most air quality measurement devices are either prohibitively expensive, overly complicated, or simply don’t monitor for every potentially dangerous pollutant in the air. IAQ addresses these issues, providing an affordable, easy-to-use solution that doesn’t compromise on detection capabilities.

“We’re incredibly proud to relaunch IAQ on Indiegogo,” said Gideon Rubin. “For the first time, people who care about breathing healthy air can easily measure indoor air quality without needing technical expertise or a large budget.”

IAQ extends its heartfelt thanks to its supporters, acknowledging that the project’s success would not be possible without their backing. The company invites everyone interested in breathing healthy air to contribute to the Indiegogo campaign and join IAQ on the journey to make managing air quality easy for all.

For more information about IAQ, its founders’ story, and the importance of indoor air quality, visit the IAQ website or the Indiegogo IAQ campaign page.

Share article on social media or email:

VGXI has long been recognized for its exceptional quality in DNA products and services, and under Mr. Whitmore’s leadership, the company aims to fuel rapid growth, consolidate its global brand positioning, and expand its client base.

CONROE, Texas (PRWEB)
May 31, 2023

VGXI Inc., a distinguished Texas-based Contract Development and Manufacturing Organization (CDMO) specializing in the production of plasmid DNA and RNA biopharmaceuticals, is pleased to announce the appointment of Mr. Jeff Whitmore as Chief Commercial Officer (CCO). With over 25 years of experience in the biotechnology industry, Whitmore brings valuable expertise to VGXI’s corporate team, having previously served as CCO for Genezen and VP of Commercial Operations at TriLink BioTechnologies.

In his role as CCO, Whitmore will drive the commercial team’s efforts to support VGXI’s newly opened headquarters and state-of-the-art production facility located at Deison Technology Park in Conroe, TX. The facility expansion is part of VGXI’s overall transition from a boutique manufacturing organization into a full-scale commercial operation, catering to the growing demands of the vaccine, immunotherapy, and cell and gene therapy industries. VGXI has long been recognized for its exceptional quality in DNA products and services, and under Mr. Whitmore’s leadership, the company aims to fuel rapid growth, consolidate its global brand positioning, and expand its client base.

“Jeff is a skillful strategist with a track record of success in product value positioning and leading transitional growth, as demonstrated during his time at TriLink,” said VGXI’s President and CEO, Young Park. “We are excited for him to join the VGXI team.”

This announcement follows the recent appointment of Mr. Jim Smith as Chief Accounting Officer, highlighting VGXI’s commitment to fostering rapid business expansion and the development of commercial services.

ABOUT VGXI, INC.

With over 20 years of experience VGXI, Inc. is a leading provider of plasmid DNA manufacturing and development services. The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and highly experienced development team. VGXI, Inc. is a GeneOne company. To learn more, visit https://www.vgxii.com.

ABOUT GENEONE LIFE SCIENCE

GeneOne Life Science Inc. (“GeneOne” KOSPI: 011000) headquartered in Seoul, South Korea is an international biotechnology company and a leading contract manufacturer of DNA plasmids for use in vaccines, gene therapies, and cell therapies. GeneOne has recently expanded into the manufacture and development of mRNA. GeneOne has maintained a focus on vaccines against emerging infectious diseases to address global needs, including in resource challenged regions. Its small molecule portfolio of immunomodulators address diseases such as prevention of upper respiratory bacterial and viral diseases, and treatment of autoimmune and inflammatory diseases. GeneOne has three products against COVID-19 in clinical development: GLS-5310 DNA vaccine (Phase I/IIa), GLS-1200 nasal spray to prevent COVID-19 infection (Phase II), and GLS-1027 to prevent the inflammation and clinical worsening for those infected with COVID-19 (Phase II). For more information, visit http://www.genels.com.

CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS

Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

Share article on social media or email:

Photo Credit: International Blue Crescent

“The situation in Türkiye remains a crisis for those impacted by the earthquakes,” said Nagulan Nesiah, Senior Program Officer, Disaster Resilience.

NEW YORK (PRWEB)
May 31, 2023

Episcopal Relief & Development is partnering with Diakonie Katastrophenhilfe (DKH) and International Blue Crescent (IBC) to provide food, shelter, supplies and mental health support to people in Türkiye affected by the earthquakes in early February 2023.

Close to 18 million people in Türkiye and Syria were impacted by the earthquakes, which killed over 55,000 people and injured almost 130,000. Before the quake, Türkiye hosted the largest number of refugees in the world, including 3.6 million Syrians. Currently, over four million people in Türkiye are living in tents or informal shelters near their damaged homes.

“The situation in Türkiye remains a crisis for those impacted by the earthquakes,” said Nagulan Nesiah, Senior Program Officer, Disaster Resilience. “We are actively engaging with our partners throughout the region to continue to assess peoples’ needs and provide support as necessary.”

With Episcopal Relief & Development’s support, DKH is responding to meet the needs of over 30,000 people in Türkiye by providing needs-based, dignified, safe and community-driven support. Their response will include providing shelter to 2,000 people, family hygiene kits for 12,000, clean water for 4,800, mental health services for 300 and staff care for 95.

Additionally, Episcopal Relief & Development is working with IBC to support 1,000 displaced people living in a camp in Özdere, Izmir, Türkiye. IBC will also provide hot meals, cleaning supplies and personal hygiene kits to those living in the camp, who range from infants to elderly people.

Please continue to pray for those who have been affected by the earthquake. Donations to the Türkiye-Syria Earthquake Response Fund will help the organization to continue to respond to communities impacted by this disaster.

ABOUT EPISCOPAL RELIEF & DEVELOPMENT

For over 80 years, Episcopal Relief & Development has been working together with supporters and partners for lasting change around the world. Each year the organization facilitates healthier, more fulfilling lives for more than 3 million people struggling with hunger, poverty, disaster and disease. Inspired by Jesus’ words in Matthew 25, Episcopal Relief & Development leverages the expertise and resources of Anglican and other partners to deliver measurable and sustainable change in three signature program areas: Women, Children and Climate.

Share article on social media or email:

Shelter Dog and Animal Control Officer

“We are at the tipping point of taking the country no-kill,” said Julie Castle, CEO, Best Friends Animal Society. “This critical mass of no-kill shelters shows that it’s possible to save every healthy and treatable pet in a shelter, and it’s sustainable.”

KANAB, Utah (PRWEB)
May 31, 2023

Best Friends Animal Society, a leading animal welfare organization working to end the killing of cats and dogs in shelters by 2025, released its annual data report today which gives the most accurate and comprehensive national overview of the number of dogs and cats that enter and exit shelters in a given year. The most noteworthy takeaway is the number of no-kill* shelters in the U.S. was at an all-time high at 57% in 2022. This is up from 24% in 2016 when Best Friends announced its goal to make America no-kill by 2025.

“We are at the tipping point of taking the country no-kill,” said Julie Castle, CEO, Best Friends Animal Society. “This critical mass of no-kill shelters shows that it’s possible to save every healthy and treatable pet in a shelter, and it’s sustainable. 93% of shelters that were no-kill in 2021 were able to maintain it the following year.”

The data also showed that the number of dogs and cats killed in U.S. shelters had a setback, with an increase to around 378,000. This was largely due to shelters experiencing higher intakes and lower adoptions. However, it also showed that nearly 60% of the increase came from just 1% of shelters, which were primarily large, municipal agencies. This means targeted programming proven to save more lives, including partnerships between no-kill and not yet no-kill shelters, as well as shelters and rescue groups, Best Friends staff embeds, cat and big-dog-focused initiatives, and advocacy work can help fix the problem.

Recent industry data revealed that dogs acquired from breeders and pet stores have been steadily increasing over the past few years. Dog adoptions stalled at just under 1 million last year, while intake was up by approximately 100,000 (the majority of which were strays, not returns). Compared to 2021 when cats were killed at twice the rate of dogs in shelters, there was a significant drop in the dog save rate in 2022 (83%, down from 87% in 2021). Fostering and adoption of dogs and cats is vital to get back on track to make shelters no-kill by 2025.

More statistics from the 2022 dataset:

• The number of pets that entered shelters nationally was 4.4 million, which is an increase of 1.6% over 2021.
• While dogs and cats entered shelters at about an equal rate, cats made up 55% of the killing, while dogs were 45%. Cats remain the most vulnerable in shelters, especially during “kitten season,” the summer months when cats reproduce and kittens flood shelters.
• The national save rate dropped slightly from 83.5% in 2021 to 81.4% in 2022. But shelter lifesaving is still trending in the right direction as the total number pets killed per year dropped by about 653K (-63.3%) since 2016.
• Five states make up 54% of the overall number of dogs and cats killed in 2022 (Texas, California, North Carolina, Florida, and Georgia).
• Vermont joined Delaware and New Hampshire as no-kill states, meaning that every shelter in each of those states was no-kill. Rhode Island, North Dakota, Maine and Montana were each on the cusp with a combined total of just over 300 dogs and cats to save to earn no-kill.

“We’ve made great progress and there is still momentum for our achievable goal, despite the small dip in lifesaving in 2022. 2025 is only two years away, so now is the time to support your local shelters. Together, let’s make every shelter and every community no-kill by 2025,” added Castle.

Individuals can help save lives by choosing to adopt from a shelter or rescue group instead of purchasing from a breeder or store, spay or neuter their pets, foster kittens or an adult dog, volunteer, donate, and advocate for proven lifesaving programming for pets.

About the data

For the past seven years, Best Friends has spearheaded a one-of-a-kind extensive data collection process that involves coordinated outreach to every shelter in America followed by additional research, data analysis, and technology development. The dataset is the most comprehensive on U.S. sheltered animals, and is based on data collected directly from shelters, state and local coalitions, government websites, and FOIA requests. From this, 95% of the animal intake in U.S. shelters is known, 5% is estimated. Best Friends has the most recently available annual data for 85% of shelters nationwide, nearly three times the amount of Shelter Animals Count and four years newer than that of the American Society for the Prevention of Cruelty to Animals.

*A 90 percent save rate is the nationally recognized benchmark to be considered “no-kill,” factoring that approximately 10 percent of pets who enter shelters have medical or behavioral circumstances that warrant humane euthanasia rather than killing for lack of space.

About Best Friends Animal Society

Best Friends Animal Society is a leading animal welfare organization working to end the killing of dogs and cats in America’s shelters by 2025. Founded in 1984, Best Friends is a pioneer in the no-kill movement and has helped reduce the number of animals killed in shelters from an estimated 17 million per year to around 378,000. Best Friends runs lifesaving programs across the country, as well as the nation’s largest no-kill animal sanctuary. Working collaboratively with a network of more than 4,200 animal welfare and shelter partners, and community members nationwide, Best Friends is working to Save Them All®. For more information, visit bestfriends.org.

Share article on social media or email: